Method for producing an intermediate product of dabigatran etexilate

Details for Australian Patent Application No. 2009259440 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Filser, Christian; Koch, Gunter; Scholz, Ulrich; Zerban, Georg; Hamm, Rainer; Dersch, Wolfgang; Hausherr, Arndt

Agent Spruson & Ferguson

Pub. Number AU-A-2009259440

PCT Pub. Number WO2009/153215

Priority 08158364.3 16.06.08 EP

Filing date 12 June 2009

Wipo publication date 23 December 2009

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

4 November 2010 PCT application entered the National Phase

  PCT publication WO2009/153215 Priority application(s): WO2009/153215

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009259451-5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases

2009259435-Method and device for relaying a radiofrequency communication between communication apparatuses located in different environments